Pharmaceuticals News and Research

RSS
China's SFDA approves TPI anti-diabetic drug Gliclazide

China's SFDA approves TPI anti-diabetic drug Gliclazide

13 May 2011
Nuvo Research acquires ZARS Pharma

Nuvo Research acquires ZARS Pharma

13 May 2011
Mylan introduces Risperidone Orally Disintegrating Tablets for schizophrenia treatment

Mylan introduces Risperidone Orally Disintegrating Tablets for schizophrenia treatment

13 May 2011
Pro-Pharmaceuticals reports net loss of $2.7 million for first quarter 2011

Pro-Pharmaceuticals reports net loss of $2.7 million for first quarter 2011

13 May 2011
Reaxys, Syngene sign multi-year contract to enhance R&D competitiveness and productivity

Reaxys, Syngene sign multi-year contract to enhance R&D competitiveness and productivity

13 May 2011
Sinovac first quarter sales increase 5.3% to $4.7 million

Sinovac first quarter sales increase 5.3% to $4.7 million

13 May 2011
Two DIFICID Phase 3 trial data in C. difficile infection presented at AGS Annual Meeting

Two DIFICID Phase 3 trial data in C. difficile infection presented at AGS Annual Meeting

13 May 2011
Groundbreaking cancer treatment studies to be unveiled at AAPS National Biotechnology Conference

Groundbreaking cancer treatment studies to be unveiled at AAPS National Biotechnology Conference

13 May 2011
ChromaDex first quarter 2011 revenue increases 31% to $2,539,245

ChromaDex first quarter 2011 revenue increases 31% to $2,539,245

12 May 2011
Trillium raises $1 million to advance TTI-1612 into clinical trials for interstitial cystitis treatment

Trillium raises $1 million to advance TTI-1612 into clinical trials for interstitial cystitis treatment

12 May 2011
Cipher first quarter net revenue decreases to $0.7 million

Cipher first quarter net revenue decreases to $0.7 million

12 May 2011
New clinical data affirms safety profile of PolyMedix's PMX-30063 in treatment of Staph infections

New clinical data affirms safety profile of PolyMedix's PMX-30063 in treatment of Staph infections

12 May 2011
Linguamatics releases I2E. Version 3.2 software for pharmaceutical companies

Linguamatics releases I2E. Version 3.2 software for pharmaceutical companies

12 May 2011
New organocatalyst now available for drug development industry

New organocatalyst now available for drug development industry

12 May 2011
Miltenyi Biotec enters partnership with TeutoCell to develop novel cell culture techniques

Miltenyi Biotec enters partnership with TeutoCell to develop novel cell culture techniques

12 May 2011
Cell Biosciences announces acquisition of Brightwell Technologies

Cell Biosciences announces acquisition of Brightwell Technologies

12 May 2011
CrystalGenomics receives draft CSR for CG400549 Phase I MAD study in Staph infections

CrystalGenomics receives draft CSR for CG400549 Phase I MAD study in Staph infections

12 May 2011
Publicis Groupe announces acquisition of Dreams Communication

Publicis Groupe announces acquisition of Dreams Communication

12 May 2011
Amira to present AM152 preclinical data in fibrotic disease at ATS Annual Meeting

Amira to present AM152 preclinical data in fibrotic disease at ATS Annual Meeting

12 May 2011
GSK, AstraZeneca and University of Manchester create new collaborative centre for inflammation research

GSK, AstraZeneca and University of Manchester create new collaborative centre for inflammation research

From The University of Manchester 12 May 2011

Terms

While we only use edited and approved content for Azthena answers, it may on occasions provide incorrect responses. Please confirm any data provided with the related suppliers or authors. We do not provide medical advice, if you search for medical information you must always consult a medical professional before acting on any information provided.

Your questions, but not your email details will be shared with OpenAI and retained for 30 days in accordance with their privacy principles.

Please do not ask questions that use sensitive or confidential information.

Read the full Terms & Conditions.

Provide Feedback